Cargando…

Efficacy of Intravitreal Bevacizumab in Treatment of Proliferative Type 2 Idiopathic Juxtafoveal Telangiectasia

OBJECTIVES: To evaluate the effectiveness of intravitreal bevacizumab (IVB) in patients with subretinal neovascularization secondary to type 2 juxtafoveal telangiectasia. MATERIALS AND METHODS: Ten eyes of 10 patients were included in this retrospective study. All cases were treated with IVB (1.25 m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baz, Ökkeş, Yılmaz, İhsan, Alagöz, Cengiz, Demircan, Ali, Perente, İrfan, Özkaya, Abdullah, Taşkapılı, Muhittin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5468527/ https://www.ncbi.nlm.nih.gov/pubmed/28630789 http://dx.doi.org/10.4274/tjo.04874

Ejemplares similares

The Efficacy of Intravitreal Bevacizumab in Vitreous Hemorrhage of Diabetic Subjects
por: Alagöz, Cengiz, et al.
Publicado: (2016)

Large Juxtafoveal Telangiectasia
por: Bonyadi, Mohammad Hossein Jabbarpour, et al.
Publicado: (2010)

Ocular Pulse Amplitude and Retinal Vessel Caliber Changes after Intravitreal Dexamethasone Implant
por: Yilmaz, Ihsan, et al.
Publicado: (2016)

Assessment of the macula and choroid in pediatric keratoconus patients
por: Yilmaz, Ihsan, et al.
Publicado: (2018)

Long Term Result of Intravitreal Bevacizumab in a Patient Newly Transformed to Proliferative Macular Telangiectasia Type 2
por: Ozkaya, Abdullah, et al.
Publicado: (2013)

Five-year Outcomes of Ranibizumab in Neovascular Age-related Macular Degeneration: Real Life Clinical Experience
por: Ozkaya, Abdullah, et al.
Publicado: (2017)

Clinical Features of Idiopathic Juxtafoveal Telangiectasis in Koreans
por: Lee, Seung Woo, et al.
Publicado: (2011)

Intravitreal Bevacizumab Treatment in Type 2 Idiopathic Macular Telangiectasia
por: Aydoğan, Tuğba, et al.
Publicado: (2016)

Anti-Vascular Endothelial Growth Factor Treatment for Proliferative Macular Telangiectasia Type 2
por: Alkin, Zeynep, et al.
Publicado: (2016)

A case of subretinal neovascularization treated with intravitreal ranibizumab in a patient with idiopathic juxtafoveal retinal telangiectasis
por: Karagiannis, Dimitrios, et al.
Publicado: (2009)

Thickness of the retinal photoreceptor outer segment layer in healthy volunteers and in patients with diabetes mellitus without retinopathy, diabetic retinopathy, or diabetic macular edema
por: Ozkaya, Abdullah, et al.
Publicado: (2017)

Refractive lenticule extraction (ReLEx) through a small incision (SMILE) for correction of myopia and myopic astigmatism: current perspectives
por: Ağca, Alper, et al.
Publicado: (2016)

Ocular and Systemic Results of Intravitreal Bevacizumab Injection in Retinopathy of Prematurity Treatment
por: Cevik, Sadik Gorkem, et al.
Publicado: (2020)

Evaluation of Contrast Sensitivity after Single Intravitreal Triamcinolone Injection for Macular Edema Secondary to Branch Retinal Vein Occlusion
por: Aras Ogreden, Tulin, et al.
Publicado: (2013)

Idiopathic Macular Telangiectasia Type 1 with Ruptured Retinal Arterial Macroaneurysm Post Intravitreal Bevacizumab
por: Nakhwa, Chinmay P., et al.
Publicado: (2015)

Intravitreal bevacizumab for parafoveal telangiectasia-associated choroidal neovascular membrane
por: Shanmugam, Mahesh P, et al.
Publicado: (2007)

Intravitreal Bevacizumab for Choroidal Neovascular Membrane in Macular Telangiectasia Type 2
por: Gonzalez Martinez, Orlando G, et al.
Publicado: (2023)

Clinical Use of Dexamethasone Implants in Resistant Macular Edema Secondary to Branch Retinal Vascular Occlusion Compared with Intravitreal Anti-Vascular Endothelial Growth Factor
por: Eris, Erdem, et al.
Publicado: (2019)

Intravitreal bevacizumab (Avastin) for the treatment of proliferative sickle retinopathy
por: Shaikh, Saad
Publicado: (2008)

Combined photodynamic therapy and intravitreal bevacizumab as primary treatment for subretinal neovascularization associated with type 2 idiopathic macular telangiectasia
por: Rishi, Pukhraj, et al.
Publicado: (2009)

The comparison of multimodal imaging findings of central serous chorioretinopathy patients in regard to the early anatomically treatment response to half-fluence photodynamic therapy: a retrospective case–control study
por: Ozkaya, Abdullah, et al.
Publicado: (2017)

Effects of Intravitreal Bevacizumab Therapy in Patients with Proliferative Diabetic Retinopathy
por: Ribeiro de Carvalho, Giuliana, et al.
Publicado: (2020)

The adjunctive use of pre-operative intravitreal bevacizumab in the setting of proliferative diabetic retinopathy
por: Al-Kharashi, Abdullah, et al.
Publicado: (2016)

Comparison of three methods of tonometry in normal subjects: Goldmann applanation tonometer, non-contact airpuff tonometer, and Tono-Pen XL
por: Yilmaz, Ihsan, et al.
Publicado: (2014)

Development of ocular hypertension and persistent glaucoma after intravitreal injection of triamcinolone
por: Kocabora, M Selim, et al.
Publicado: (2008)

Intravitreal bevacizumab treatment for retinal neovascularization and vitreous hemorrhage in proliferative diabetic retinopathy
por: El-Batarny, Ashraf M
Publicado: (2007)

Intravitreal bevacizumab prior to vitrectomy for proliferative diabetic retinopathy: a systematic review
por: Dervenis, Panagiotis, et al.
Publicado: (2021)

Intravitreal ranibizumab in the treatment of choroidal neovascularization secondary to morning glory syndrome in a child
por: Özkaya, Abdullah, et al.
Publicado: (2016)

Comparison of intravitreal ranibizumab between phakic and pseudophakic neovascular age-related macular degeneration patients: Two-year results
por: Ozkaya, Abdullah, et al.
Publicado: (2015)

The Effect of Adjuvant Intracameral Triamcinolone Acetonide on the Surgical Results of Trabeculectomy with Mitomycin C
por: Alagöz, Neşe, et al.
Publicado: (2016)

Macular Oedema in Idiopathic Macular Telangiectasia Type 1 Responsive to Aflibercept but Not Bevacizumab
por: Shibeeb, O'Sam, et al.
Publicado: (2014)

Clinical Performance of Toris K Contact Lens in Patients with Moderate to Advanced Keratoconus: A Real Life Retrospective Analysis
por: Yilmaz, Ihsan, et al.
Publicado: (2016)

Intravitreal Bevacizumab as a Primary Treatment for Idiopathic Choroidal Neovascularization
por: Cheema, Rizwan A., et al.
Publicado: (2011)

Intravitreal bevacizumab
por: Khamar, Bakulesh M
Publicado: (2018)

Early Vitreous Hemorrhage after Vitrectomy with Preoperative Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy
por: Sato, Tatsuhiko, et al.
Publicado: (2013)

The Role of Epiretinal Membrane on Treatment of Neovascular Age-Related Macular Degeneration with Intravitreal Bevacizumab
por: Alkin, Zeynep, et al.
Publicado: (2013)

Is subretinal surgery feasible for a non-responsive juxtafoveal type 2 choroidal neovascular membrane?
por: Quiroz-Mercado, Hugo, et al.
Publicado: (2019)

Retro-mode imaging of fibrovascular membrane in proliferative diabetic retinopathy after intravitreal bevacizumab injection
por: Suzuma, Kiyoshi, et al.
Publicado: (2011)

Effect of Intravitreal Bevacizumab on Vascular Endothelial Growth Factor Expression in Patients with Proliferative Diabetic Retinopathy
por: Chung, Eun Jee, et al.
Publicado: (2011)

Effects of an Intravitreal Bevacizumab Injection Combined With Panretinal Photocoagulation on High-Risk Proliferative Diabetic Retinopathy
por: Shin, Yong Woon, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_m211e23jr0bnvi38q2qpq0s980